Search for: "Pfizer Ireland Pharmaceuticals"
Results 21 - 36
of 36
Sorted by Relevance
|
Sort by Date
29 Aug 2011, 7:56 am
That is the case for Anthony Bruno, the Executive Vice President, Corporate Development of Warner Chilcott plc (WCRX), a “global specialty pharmaceutical company” headquartered in Dublin, Ireland. [read post]
7 Nov 2013, 4:57 pm
In case you’re having a hard time figuring out who they’re fingering, I’ll help you out: Apple, Google, Microsoft, Pfizer and Dell. [read post]
13 Mar 2024, 7:24 pm
§ 1.750, applicant is required to submit the following to the Office: Evidence that Opko Biologics Ltd. is expressly authorized to rely upon the regulatory review activities by Pfizer Ireland Pharmaceuticals (Pfizer), the marketing applicant before the Food and Drug Administration to support the application for patent term extension of U.S. [read post]
16 Jul 2015, 4:00 am
Pfizer Ireland Pharmaceuticals 2006 FC 1465, where Lilly sought to impeach Pfizer’s patent on the Cialis drug and sought to get access to communications between the inventors and the U.K. [read post]
2 Jul 2015, 4:00 am
Pfizer Ireland Pharmaceuticals, 2006 FC 1465). [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
2 Nov 2011, 2:00 am
Research & Diagnostic Systems (Pharma Patents) US: Roundup Ready® Soybeans: Patent exhaustion in self-replicating biotechnologies (IP Osgoode) US: FDA continues efforts to expand power over intrastate commerce (FDA Law Blog) US: Defendants’ persistence in pursuing “baseless inequitable conduct claim” justified award of attorneys’ fees to plaintiff: Pfizer et. al v. [read post]
19 Sep 2014, 5:50 pm
Steven gave an example of the Canadian Federal Court case of Lilly Icos v Pfizer Ireland Pharmaceuticals (2006) FC 1465, where communications between Pfizer and a UK patent attorney was held not to be privileged. [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
20 Jun 2008, 8:07 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Associated Press – AP files seven DMCA takedowns against Drudge Retort blog over users linking to its stories: (The Trademark Blog), (Techdirt), (Out-Law), (Electronic Frontier Foundation), (IPKat), (The Trademark Blog), ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v… [read post]
4 Feb 2019, 4:33 am
Thus, it should be borne in mind that the paediatric extension is ancillary to the SPC itself, and thus does not constitute a distinct IP right but merely alters the term of an SPC, as recently acknowledged by the CJEU in Pfizer Ireland (C-681/16). [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt) Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
13 Apr 2014, 8:59 am
For example, the US Congress,[2] the European Union[3] and its member states including the UK[4] and Ireland,[5] Australia[6] and others have been re-examining their copyright laws in light of the challenges posed by digital technologies. [read post]
